Technology and Transparency Are Watchwords For This Life-Science Company
Reginald Swift, CEO and founder of Rubix LS, is working to accelerate cures for rare diseases by utilizing new technology and increasing transparency between patients and companies.
Interview with Reginald Swift, the CEO of Rubix LS.
The following is the pre-interview with Reginald Swift. Be sure to watch the recorded interview above.
Revenue model: Currently providing consultation services to commercial entities as well as providing innovation towards the federal government via grants and contracts.
Scale: Our devices are currently in clinical trials, but our commercial entity has reached a network of 60 subject matter experts in a number of regions that have supported the industry through various capacities.
What is the problem you solve and how do you solve it?
Transparency of the product development life-cycle for life-science companies. Much of the public is dismayed by the lack of transparency and apparent accountability companies make toward ensuring public health concerns are met. We’re bridging that trust between patient and the companies directly with ensuring the voice of the patient throughout their stages, whether in clinical trials or market consumption of product, that feedback is secured and data intelligence along with our insight is shared with the entities. With the ultimate goal of companies including a diverse population set to truly enable them to build better products that are precision medicine and therapies for people of all backgrounds.
More about Rubix LS:
Rubix LS is a digital life science company looking to shorten the gap between product innovation and effective patient outcomes by enabling technology to provide transparent measures to induce greater product efficacy.
Reginald Swift. Photo Credit: Rubix LS
Reginald Swift’s bio:
Are you part of the good crowd? Join GoodCrowd.school, school for changemakers today.
The post Technology and Transparency Are Watchwords For This Life-Science Company appeared first on Your Mark On The World.